جست‌وجوی استاد و پژوهشگر

• Immunology
• Systems Biology
• Genomics
• +۴ مورد دیگر

Dr. Masahiro Ono is a Reader in Immunology at Imperial College London's Department of Life Sciences, within the Faculty of Natural Sciences. He leads research on T-cell regulation, focusing on autoimmunity, infections, and cancer. His lab pioneered the Tocky system, using Fluorescent Timer proteins to study T-cell activity dynamics in vivo. Dr. Ono holds affiliations with the CRUK Convergence Science Centre, Infection and Immunity, and Integrative Systems Biology. His academic journey includes an MD from Kyoto University (1993-1999) and a PhD in regulatory T cells (2002-2006). He was awarded a HFSP Fellowship (2009) and BBSRC David Phillips Fellowship (2012), establishing his UCL lab before joining Imperial in 2015. Research Interests : Dr. Ono's work bridges immunology, genomics, and systems biology. His lab explores T-cell activation mechanisms, tumor immunology, and bioinformatics tools for single-cell analysis. Key innovations include the Tocky system for real-time cell kinetics tracking and integrative approaches like GatingTree for cytometry data analysis. Awards : HFSP Fellowship (2009) BBSRC David Phillips Fellowship (2012) Grants & Advising : Dr. Ono's grants have supported projects on viral latency, tumor microenvironment modulation, and immune checkpoint therapies. His lab actively collaborates on translational research, though specific grant details are not listed here. Labs & Teams : His lab at Imperial focuses on Tocky-based technologies and interdisciplinary convergence science through the CRUK Centre. Collaborations span virology, oncology, and bioengineering to address unmet clinical needs in immunotherapy.

Poornima Ramananمشاهده پروفایل

استاد بالینی

• Infectious Diseases
• Transplant Medicine
• Clinical Microbiology
• +۳ مورد دیگر

Poornima Ramanan, MD, is a Clinical Professor in the Department of Infectious Diseases at Oregon Health & Science University (OHSU), where she joined in 2022. Previously, she held faculty positions at the University of Colorado, focusing on transplant infectious diseases. Her expertise includes managing infections in immunocompromised patients, particularly those undergoing solid organ or hematopoietic stem cell transplantation. She also has a strong interest in tropical medicine and infections affecting underserved populations. Dr. Ramanan completed her medical degree (M.B.B.S.) at Coimbatore Medical College in India. She pursued postgraduate training in Internal Medicine at Lincoln Medical and Mental Health Center in New York, followed by infectious diseases fellowship at Harlem Hospital and additional fellowships in transplant infectious diseases and clinical microbiology at the Mayo Clinic in Minnesota. She is board-certified in Infectious Diseases and Medical Microbiology. Her research focuses on improving diagnostics for fungal infections, optimizing management of post-transplant infections, and addressing challenges in tropical disease diagnosis. Over 38 publications highlight her work in areas like HTLV-1 transmission, cytomegalovirus management in transplant recipients, and syndromic panel-based testing in microbiology. Dr. Ramanan is actively involved in medical education, particularly in training future clinicians in infectious diseases and transplant medicine. Her clinical practice emphasizes compassionate care for complex immunocompromised patients while advancing evidence-based infection control strategies.

Fabiola Aghakhani Zandjani-Martinمشاهده پروفایل

پژوهشگر ارشد

• HIV/AIDS Research
• HTLV-1 Pathogenesis
• Public Health Policy
• +۳ مورد دیگر

Dr. Fabiola Aghakhani Zandjani-Martin is an Honorary Senior Research Fellow at the University of Queensland's School of Public Health. Her research focuses on HTLV-1 (human T-lymphotropic virus type 1) pathogenesis, HIV/AIDS epidemiology, and public health policy. She leads and contributes to global studies on HTLV-1-associated myelopathy (HAM/TSP), cancer survival mechanisms linked to sodium channel-inhibiting drugs, and HIV care transitions. Key affiliations include collaborations with institutions in Australia, Japan, Brazil, and the UK. Her work spans clinical trials (e.g., the HAMLET-P corticosteroid trial for HAM/TSP) and systematic reviews, such as consensus guidelines for HAM/TSP management. She also investigates intersectional topics like HTLV-1 and SARS-CoV-2 interactions, and cancer therapeutics. Education : No explicitly stated degrees, but inferred expertise from publications in virology, immunology, and public health. Research Themes : HTLV-1 virology, HIV care outcomes, drug-cancer survival links, and neuroimmunological disorders. Grants/Projects : Involved in multi-country clinical trials and observational studies funded by global health initiatives. Her articles highlight contributions to HTLV-1 epidemiology (e.g., Queensland's adult leukemia/lymphoma study), HIV transition care (mortality analysis in young adults), and methodological advances in HTLV-1 detection.

• Virology
• Infectious Diseases
• Molecular Diagnostics
• +۳ مورد دیگر

Antonio Aguilera Guirao is an Associate Professor at the Department of Microbiology and Parasitology, Faculty of Medicine and Dentistry, University of Santiago de Compostela. He is affiliated with the Instituto de Investigación del Medio Acuático para una Salud Global (iARCUS) and the Agrupación Estratégica BioReDes . His research focuses on viral diagnostics, hepatitis viruses (HBV, HCV, HDV), HIV/AIDS, and HTLV-1. He earned his PhD in 1990 with a thesis on HIV-1 prognosis markers. His work emphasizes molecular epidemiology, public health interventions, and optimizing diagnostic strategies for viral infections. Key projects include SARS-CoV-2 wastewater surveillance, hepatitis delta detection, and expanding HTLV screening in Europe. Education: PhD in Microbiology (1990, USC) with a thesis on HIV-1 immunoblot assays. Extensive postdoctoral expertise in virology and clinical microbiology. Research interests span viral hepatitis management, antiretroviral resistance, and molecular diagnostics. His recent studies address hepatitis C one-step diagnosis, SARS-CoV-2 variant tracking, and optimizing HTLV-1 screening in high-risk populations. He collaborates on national and international guidelines for viral hepatitis elimination. Advising: No advisees listed. Grants: Active in hepatitis and HIV research funding initiatives. Labs: iARCUS and BioReDes focus on aquatic health and sustainable bioresource management, respectively.

Hari Arthanariمشاهده پروفایل

دانشیار

• Structural Biology
• Biochemistry
• Biophysics
• +۵ مورد دیگر

Hari Arthanari is an Associate Professor in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School . His research focuses on protein-protein interactions and transcriptional Regulation in disease contexts, utilizing NMR spectroscopy , biophysical assays , and cell-based models . He operates the Arthanari Laboratory at Dana-Farber Cancer Institute, with a lab size of 5-10 members. Develops novel NMR methods for fragment screening and metabolite analysis Investigates transcriptional condensates and translation machinery dysregulation in cancer Applies integrative structural biology to therapeutic target discovery Research trends in his publications highlight therapeutic targeting of protein interactions across diverse diseases including cancer and viral infections . His work spans method development for NMR experiments, metabolomics marker identification , and structural characterization of both viral and human proteins. Articles frequently employ techniques like fluorine NMR , 15N TROSY experiments , and computational screening for drug candidate discovery. Scientific awards or formal recognition were not explicitly mentioned in the provided texts. His lab's publications emphasize collaborative multi-institute research and open-source drug discovery platforms , though no specific student advising or grant details were extracted. The Arthanari Lab (website: artlab.dana-farber.org) maintains focus on structural and functional characterization of proteins involved in disease mechanisms, particularly through NMR-derived metabolomics data and protein-ligand interaction identification .

B. Hilda Yeمشاهده پروفایل

دانشیار

• Lymphoma Development
• Transcription Regulation
• Cell Signaling
• +۳ مورد دیگر

B. Hilda Ye is an Associate Professor in the Department of Cell Biology at Albert Einstein College of Medicine. Her research focuses on understanding how transcriptional regulation and cell signaling govern lymphocyte differentiation and lymphoma development, with a current emphasis on diffuse large B-cell lymphoma (DLBCL) and adult T-cell leukemia/lymphoma (ATLL). Her work bridges molecular pathogenesis, cancer genetics, and tumor-host interactions to uncover mechanisms underlying lymphomagenesis and therapeutic resistance. Her research program investigates three key areas: molecular mechanisms of B and T cell development, perturbations in these processes during lymphoma formation, and the development of mechanism-based therapies. Notably, her lab has elucidated roles for BCL6, STAT3, and the IL-6/Jak/STAT3 pathway in DLBCL, and recently shifted focus to ATLL, particularly its genomic and clinical differences between North American and Japanese cohorts. This includes studying epigenetic mutations, immune evasion strategies, and the potential of epigenetic therapies. Her publications highlight advancements in understanding HTLV-1-driven ATLL pathogenesis, genomic landscapes of ATLL, and therapeutic approaches targeting PAK kinase and immune checkpoint pathways. Collaborations with clinical groups at Montefiore Medical Center leverage unique access to patient samples for translational studies. Research trends in her articles emphasize genomic profiling, immune modulation, and targeted therapies for hematologic malignancies. Her work underscores the importance of integrating molecular, genetic, and clinical data to address unmet therapeutic needs in T-cell malignancies. Labs and teams: Her laboratory at Albert Einstein College of Medicine focuses on ATLL and lymphoma biology, with ongoing studies on BCL6’s role in ATLL identity, genomic evolution between ATLL subtypes, and overcoming immunosuppression in ATLL patients.

Karin Musier-Forsythمشاهده پروفایل

استاد

• Biochemistry
• Virology
• Molecular Biology
• +۳ مورد دیگر

Karin Musier-Forsyth is the Ohio Eminent Scholar in Biological Macromolecular Structure and Professor of Chemistry and Biochemistry at The Ohio State University. She holds affiliations with the College of Arts and Sciences and leads the KMF Lab, focusing on RNA-protein interactions in viral replication and translational fidelity. Her career includes roles at the University of Minnesota (1992-2007) and postdoctoral training at MIT (1989-1992) under Paul Schimmel after earning her Ph.D. from Cornell University (1989). Research emphasizes HIV-1, HTLV-1, and SARS-CoV-2 mechanisms, including tRNA packaging, RNA chaperone activities, and aminoacyl-tRNA synthetase roles in genetic diseases. Key projects involve viral RNA structure-function relationships, translational quality control, and disease-linked mutations in aaRS enzymes. She has published over 200 peer-reviewed works, edited Journal of Biological Chemistry (since 2018), and co-directed the NIH T32 Predoctoral Training Program since 2011. Awards include Camille Dreyfus Teacher-Scholar (1996), AAAS Fellow (2009), and William H. Kadel Alumni Medal (2014). Labs/Teams: KMF Lab at OSU explores retroviral biology, RNA-protein dynamics, and translational fidelity mechanisms with interdisciplinary biochemical and biophysical approaches.

Chantelle Ahlenstielمشاهده پروفایل

پژوهشگر ارشد

• Virology
• Infectious Diseases
• Gene Therapy
• +۳ مورد دیگر

Dr. Chantelle Ahlenstiel is a Senior Research Fellow at the Kirby Institute, University of New South Wales, in the Immunovirology & Pathogenesis Program. She holds a Bachelor of Advanced Science (Hons 1st class) from the University of Sydney (2000) and a PhD in Infectious Diseases from the same university (2004). She was awarded an NIH Visiting Fellowship for postdoctoral training at the Vaccine Research Center, NIH (2004-2009). Her research focuses on RNA-directed epigenetic silencing of HIV-1 and SIV, with projects including live cell imaging of siRNA trafficking, the role of F-actin in transcriptional gene silencing, and in vivo studies using humanized mouse models. She also investigates nanoparticle delivery of si/shRNA for HIV-1 therapy. Dr. Ahlenstiel has received the NIH Visiting Fellowship award. She supervises one Master's and two PhD students. She is the recipient of the NHMRC Project Grant APP1128012. She leads research in the Immunovirology & Pathogenesis Program at the Kirby Institute.

Antoine Gessainمشاهده پروفایل

استاد پژوهشی

• Virology
• Epidemiology
• Retrovirology
• +۱۲ مورد دیگر

Antoine Gessain is a leading medical virologist and Head of Structure at the Oncogenic Virus Epidemiology and Pathophysiology (EPVO) unit at the Institut Pasteur in Paris. He received his MD and PhD from Parisian universities and has been instrumental in advancing research on retroviruses and oncogenic viruses since the unit's founding in 2001. He leads multiple research projects and collaborates with international institutions across Central Africa, French Guiana, and Peru. His research interests include: Virology and molecular epidemiology of HTLV-1, HHV-8, and simian foamy viruses Zoonotic transmission of retroviruses from primates to humans Genetic diversity and global dissemination of oncogenic viruses Pathogenesis of HTLV-1-associated diseases such as myositis and neuromyelopathy Immunological responses to retroviral infections His recent publications (2022–2025) reflect a strong focus on emerging viral threats, structural virology, and the molecular mechanisms of viral entry and immune neutralization. Notably, his team has contributed key insights into the structure of foamy virus envelope proteins, seroreactivity to ebolaviruses in Central Africa, and the epidemiology of HTLV-1 transmission in rural populations. Dr. Gessain has received no explicitly mentioned scientific awards in the provided text. However, his role as principal investigator on multiple funded projects and his extensive publication record underscore his scientific impact. He is actively involved in mentoring researchers and post-doctoral fellows, though specific PhD advisees are not listed. His work is supported by long-term collaborations with the Réseau International des Instituts Pasteur, CIRMF in Gabon, and Peruvian academic institutions. He also contributes to teaching at the Institut Pasteur, co-directing courses in systematic virology and infectious disease circulation. His research unit operates at the intersection of basic virology, public health, and clinical applications, with strong links to hospital departments and animal care facilities for translational research.

Jean-Pierre Vartanianمشاهده پروفایل

پژوهشگر

• Virology
• Molecular Virology
• Viral Mutagenesis
• +۷ مورد دیگر

Jean-Pierre Vartanian is a researcher in the Virology department at the Institut Pasteur in Paris, France. He is actively involved in research on viral mutagenesis, host restriction factors, and the role of APOBEC3 enzymes in viral evolution and carcinogenesis, particularly in the context of hepatitis B virus and retroviruses. His research focuses on understanding how host cellular factors such as APOBEC3 enzymes and hypoxia-induced proteins influence viral replication and genome stability. He investigates mechanisms of viral restriction, DNA editing, and the interplay between viral infection and innate immune responses, with implications for cancer development and antiviral strategies. The recent publications highlight a strong trend in molecular virology, especially in host-virus interactions, mutagenesis, and DNA damage responses. His work frequently explores how cellular stress conditions like hypoxia modulate antiviral defenses and how APOBEC3 family proteins contribute to both antiviral activity and genomic instability. Genetic and molecular mechanisms of viral restriction Role of APOBEC3 enzymes in viral evolution and cancer Hepatitis B virus-host interactions Mutagenesis in emerging viruses (e.g., Monkeypox) Innate immunity and DNA damage response He contributes to educational programs at the Institut Pasteur, including the annual Pasteur Course Emerging Viruses , Cours Pasteur Virologie fondamentale , and several MOOCs such as Viral Outbreaks and Pandemics and Viruses and Human Cancers , indicating active mentorship and knowledge dissemination roles. While specific grants or advising relationships are not detailed, his collaborations with prominent scientists like Simon Wain-Hobson and Rémi Suspène suggest strong research network involvement. Jean-Pierre Vartanian is associated with the Institut Pasteur’s research ecosystem, contributing to projects in virology and host-pathogen interactions, particularly within teams focused on viral physiopathology, virus-cell stress, and immunity.

De Gaulle I. Chigbuمشاهده پروفایل

استاد

• Ophthalmology
• Immunology
• Viral Diseases
• +۳ مورد دیگر

De Gaulle I. Chigbu is a Professor at Salus University Pennsylvania College of Optometry and a Staff Optometrist at The Eye Institute at Falls Center. His primary clinical specialty is Comprehensive Eye Care. Education includes: MS in Immunology from Drexel University College of Medicine Residency in Primary Care at Pennsylvania College of Optometry MSc in Clinical Optometry from City, University of London OD from Abia State University, Nigeria Research focuses on viral ocular infections (e.g., herpes, Zika, adenovirus), allergic eye diseases (conjunctivitis, vernal keratoconjunctivitis), and immunopharmacology. He has published extensively on antiviral therapies, inflammatory mechanisms, and novel drug targets. His publications demonstrate expertise in: Viral keratitis pathogenesis and management Immunology of ocular surface diseases Flavonoid-based anti-inflammatory strategies Host-pathogen interactions in chronic infections Professional honors include Fellowships from the American Academy of Optometry and College of Optometrists (UK), Diplomate status in Comprehensive Eye Care, and recognition for Academic Excellence in Immunology. He serves as Executive Editor of 'Advanced Concepts in Human Immunology' and holds adjunct roles in immunology research. Grants and collaborations involve: NIH-funded studies on HTLV-1 neurotropism Industry partnerships for ocular drug development Global health initiatives targeting tropical viral diseases Labs/teams include: Salus University Eye Institute Research Division Collaborations with Drexel University immunology labs

Pooja Jainمشاهده پروفایل

استاد

• Retrovirology
• Immunotherapy
• Neuroinflammation
• +۳ مورد دیگر

Pooja Jain, PhD, is a Professor in the Department of Microbiology & Immunology at Drexel University College of Medicine, with a joint appointment in Neurobiology & Anatomy. She co-directs the Master of Science in Immunology Program and chairs the 2024 Biennial Conference on Retrovirology. Her research focuses on retrovirus-associated cancers (e.g., HTLV-1/HTLV-2), neuroinflammation mechanisms, and exosome biology. Education: PhD - Microbiology, Central Drug Research Institute, India (2001) MS - Biology, CSJM Kanpur University (India) BS - Biology/Chemistry, CSJM Kanpur University (India) Research Interests: Risk factors for AIDS-related lymphomas linked to EBV and ART use MEF-2 signaling as a therapeutic target for HTLV-1-induced ATLL Role of exosomes/ESCRT machinery in HTLV-1 neuroinflammation (HAM/TSP) Her work investigates immune checkpoint modulation, exosome cargo dynamics, and drug repurposing (e.g., apigenin) to combat retroviral diseases. Awards & Honors: AAI Travel Awards (2022-2024) Elected AOA Medical Honor Society (2023) 20-year Drexel Service Award (2023) Advising & Grants: Advises graduate students Salwa Ahmed (MS) and Noor Qureshi (MD) Recipient of NIH/NIDA grants and institutional funding Leads SKCC HIV-Cancer Team 4 collaborations Labs & Affiliations: Member of the Sidney Kimmel Cancer Center’s Immune Cell Regulation Program, American Society for Exosomes and Microvesicles, and multiple retrovirology societies. Her lab studies HTLV-1 pathogenesis using exosome isolation, CRISPR-Cas9, and in vivo imaging of myeloid cell trafficking.

Fleckenstein Bernhardمشاهده پروفایل

استاد

• Virus oncology
• Molecular biology of herpesviruses
• Molecular biology of retroviruses
• +۳ مورد دیگر

Bernhard Fleckenstein was a Professor of Virology and Director of the Institute for Clinical and Molecular Virology at the University of Erlangen-Nuremberg from 1978 until his passing in 2021. He held prior academic positions, including Associate Professor at Harvard Medical School (1976-1978) and Assistant Professor roles at institutions in Germany. His research focused on virus oncology and the molecular biology of herpes and retroviruses, contributing to understanding viral mechanisms in cancer and immune system interactions. Key honors include the Max Planck Prize (1991), Aronson Award (1991), and the Bavarian Order of Merit (2006). Fleckenstein's work addressed viral transformation of T-cells, oncogenesis, and viral-host interactions. His publications span molecular virology, cancer biology, and immunology, with notable contributions on cytomegalovirus regulation, herpesvirus-induced lymphomas, and HIV entry inhibition. Advising and grant activities are not explicitly detailed, but his academic leadership and research output reflect significant contributions to virology. His legacy includes foundational studies on viral oncogenes and cellular receptors for pathogens like Kaposi's sarcoma-associated herpesvirus.

• Cell Biology
• Laboratory Medicine
• Advanced Microscopy
• +۵ مورد دیگر

Maria Omsland serves as an Associate Professor in the Department of Safety, Chemistry and Biomedical laboratory sciences at Western Norway University of Applied Sciences (HVL) in Bergen. Her office is located at KRONSTAD D361. With a PhD in Medical Cell Biology, she functions as both a Biomedical Laboratory Scientist and Cell Biologist specializing in advanced cellular mechanisms. Dr. Omsland's research spans multiple critical areas of cellular pathology, with particular emphasis on cell death mechanisms and cell communication in blood and blood vessels. Her expertise encompasses Cell Biology, Laboratory Medicine, and Advanced Microscopy techniques. Her work bridges theoretical knowledge with practical applications in the biomedical laboratory technician profession. Analysis of Dr. Omsland's publication record reveals a consistent focus on hematological malignancies, particularly chronic myeloid leukemia (CML). Her research demonstrates sophisticated integration of virology, immunology, and cancer biology, with multiple publications examining cellular communication mechanisms like tunneling nanotubes and neutrophil extracellular traps in leukemia contexts. The progression of her work shows increasing sophistication in cellular analysis techniques, moving from basic cell line studies to advanced single-cell immune profiling in patient samples. Her current research projects include 'Non-BCR::ABL1 dependent resistance in chronic myeloid leukemia' and investigations into neutrophil extracellular traps (NETs) in myeloid leukemia and their association with cardiovascular side effects of tyrosine kinase inhibitors. Dr. Omsland actively supervises bachelor's, master's projects and seeks PhD candidates, emphasizing practical relevance to the biomedical laboratory technician profession while maintaining strong research connections to theoretical teaching.

Suraiya Rasheedمشاهده پروفایل

استاد

• Proteomics
• Virology
• Molecular Biology
• +۳ مورد دیگر

Dr. Suraiya Rasheed is a Professor of Pathology at the Keck School of Medicine of the University of Southern California. Her research focuses on proteomics of cancer and neuronal cells, HIV infection mechanisms, and molecular characterization of human retroviruses (e.g., HTLV-I/II, HIV-I/II) linked to cancer and AIDS. She leads the Laboratory of Viral Oncology and AIDS Research, exploring viral oncogenes, drug resistance mutations, and AIDS-related lymphoma pathogenesis. Education: PhDs from the University of London (1964) and Osmania University (1958), with a Master’s in Science from Osmania University (1955). A Fellow of the Royal College of Pathologists (FRC Path) since 1993, she is affiliated with the American Society for Microbiology and the International AIDS Society. Key research themes include HIV proteomics, retroviral genomics, and translational studies on antiviral therapies. Recent work highlights biomarker discovery for HIV-associated heart disease and novel angiogenic pathways. Over 60 peer-reviewed articles span virology, oncology, and molecular diagnostics, with contributions to AIDS clinical trials and drug resistance analysis. Her laboratory bridges basic science and clinical application, addressing viral pathogenesis and therapeutic strategies in both cancer and infectious diseases. Grants and collaborations support her work in global health and molecular epidemiology.